MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Carbon Monoxide Poisoning-Induced Parkinsonism: A Prospective Study of Clinical and Neuroimage Correlation

    J-Y. Li, M-C. Chou, P-H. Lai (Kaohsiung, Taiwan)

    Objective: To investigate prospectively the nigrostriatal system in patients with delayed post-anoxic Parkinsonism by TRODAT-1 brain SPECT serially and to correlate the neuropsychiatric performance and…
  • 2018 International Congress

    SYN120 (a Dual 5-HT6/5-HT2A Antagonist) Study to Evaluate Safety, Tolerability and Efficacy in Parkinson’s Disease Dementia (SYNAPSE): Phase 2a Study Results

    H. Fernandez (Cleveland, OH, USA)

    Objective: To evaluate the safety and preliminary efficacy of SYN120 in patients with Parkinson's disease dementia (PDD). Background: SYN120 is an antagonist of serotonin receptors…
  • 2018 International Congress

    Outcomes of a Prospective, Multi-center International Registry of Deep Brain Stimulation for Parkinson’s Disease

    G. Deuschl, R. Jain, H. Scholtes, A. Wang, M. Barbe, S. Paschen, A. Andrea Kühn, M. Pötter-Nerger, J. Volkmann, J. Vesper (Kiel, Germany)

    Objective: The objective this report is to describe collected outcomes from a large scale registry of a Deep Brain Stimulation (DBS) system capable of Multiple…
  • 2018 International Congress

    Update on The Personalized Parkinson Project: Partnering with Patients to Understand Disease Progression Through a Multi-Dimensional Approach

    B. Bloem, R. Kapur, T. v/d Zande, M. Faber, W. Marks, Jr (Nijmegen, Netherlands)

    Objective: Enrollment for The Personalized Parkinson Project (PPP) is underway. Co-design and mutual partnership between patients and researchers is a key characteristic of the project…
  • 2018 International Congress

    Contribution of ATP-sensitive potassium channels in the subthalamic nucleus neurons towards Parkinson’s disease

    C. Mahapatra, R. Manchanda (Mumbai, India)

    Objective: This study describe a quantitative investigation to explore the modulating effects of the ATP-dependent Potassium channel (KATP) ion channel conductance on spike patterns in…
  • 2018 International Congress

    Remotely supervised home-based aerobic exercise for Parkinson patients

    N. vd Kolk, N. de Vries, B. Post, B. Bloem (Nijmegen, Netherlands)

    Objective: To evaluate: (1) the adherence to long-term home-based aerobic exercise (AE) in patients with Parkinson’s disease (PD); and (2) whether AE affords clinically relevant…
  • 2018 International Congress

    Weight loss and nutritional status in Parkinson’s disease patients under levodopa/carbidopa intestinal gel infusion treatment

    M. Fabbri, M. Zibetti, L. Beccaria, A. Romagnolo, E. Montanaro, J. Ferreira, L. Lopiano (Lisbon, Portugal)

    Objective: To investigate the occurrence of weight loss (WL) in Parkinson’s disease (PD) patients under LCIG treatment and to analyse its relationship with the nutritional…
  • 2018 International Congress

    Intranasal Delivery of Bromocriptine loaded Lipid Nano Carriers for Enhanced Brain Delivery in Parkinson’s disease

    S. V G, P. Vavia (Mumbai, India)

    Objective: The objective of this research work is to develop a lipid nanocarrier system of Bromocriptine and evaluate its increased efficacy in the management of…
  • 2018 International Congress

    Single centre experiences of directional leads in Parkinson patients

    U. Scheller, G. Wenzel, R. Lofredi, D. Kroneberg, K. Faust, G.H. Schneider, A.A. Kühn (Berlin, Germany)

    Objective: To evaluate the use of segmented lead technology in clinical routine in patients undergoing subthalamic nucleus deep brain stimulation (STN-DBS). Background: Due to the…
  • 2018 International Congress

    Subthalamic deep brain stimulation is safe and effective treatment for elderly patients with Parkinson’s disease

    J. Youn, M. Kim, JH. Park, K.R. Cho, J.H. Ahn, JI. Lee, J.W. Cho (Seoul, Republic of Korea)

    Objective: To investigate the safety and efficacy of subthalamic nucleus (STN) deep brain stimulation (DBS) in elderly patients with Parkinson's disease (PD). Background: Even though…
  • « Previous Page
  • 1
  • …
  • 265
  • 266
  • 267
  • 268
  • 269
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley